Analyst Gil Blum of Needham maintained a Buy rating on Arcellx Inc (ACLX – Research Report), retaining the price target of $96.00. Gil ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on ...

Israel's parliament voted Monday to ban the operations of the United Nations agency for Palestinian refugees, the main humanitarian aid agency operating in Gaza. Israeli Prime Minister Benjamin ...

West Pharmaceutical Services Inc (NYSE:WST) reported solid third-quarter performance with revenues and adjusted EPS at the higher end of expectations. The company increased its adjusted EPS guidance ...

ABUJA – THE Director General, African Centre for Supply Chain, ACSC, Dr Obiora Madu, Thursday, declared that supply chain services remain catalyst to the country’s pharma sector and others.

Good day and thank you for standing by. Welcome to the Q3 2024 West Pharmaceutical Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

The pharmaceuticals, biologics, vaccines and consumer healthcare products manufacturer forecast sales between $2.88 billion and $2.91 billion as well adjusted earnings per-share in the range of $6 ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

State-run Bharat Sanchar Nigam Limited (BSNL) introduced its new logo along with seven services aimed at citizens. The new initiatives focus on security, affordability, and reliability.

West Pharmaceutical Services (WST) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $2.16 per share a year ...